Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New revision label v3.5.5 was added to the record history, replacing the previous v3.5.4. This indicates an update to the page's versioning information.
    Difference
    0.1%
    Check dated 2026-06-08T03:59:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The revision label updated from v3.5.3 to v3.5.4, indicating a newer build of the page. This change is a metadata/version update and does not affect the study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-05-17T10:26:16.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    This updates the page’s displayed platform/interface revision from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:47:22.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.5.2 and removes Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:36:35.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    System revision history updated to add v3.5.0 and remove v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:21:28.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-06T19:07:27.000Z thumbnail image

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.